Atlas Trials

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Clinical trial NCT03442725 · COMPLETED

Trial details

NCT number
NCT03442725
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2018-02-09
Primary completion
2018-04-27
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.